Literature DB >> 23169512

Advocates' perspective: neoadjuvant chemotherapy for breast cancer.

Jane Perlmutter, Susan Axler, Carole Baas, Barbara J Beckwith, Amy Bonoff, Susan Brain, Maryellen Delapine, Margaret Devine, Elizabeth Frank, Valerie Fraser, Marjorie Gallece, Cindy Geoghegan, Hiam Hamade, Diane Heditsian, Bonnie Hirschhorn, Stephen Kandell, Deborah Laxague, Barbara Lestage, Maria Lyzen, Debra Madden, Shirley A Mertz, Beverly J Parker, Nancy Roach, Nancy Sauers, Linda Vincent, Dorothy Waddell, Maria Wetzel, Kimberly Wright.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23169512     DOI： 10.1200/JCO.2012.44.1824

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  NCI's publication affiliation conundrum: Reframing innovation to incentivize an equitable path for advocate representation.

Authors:  Susan Samson; Jason J Northey; Irene Acerbi; Andrei Goga; Carl L Flink; Valerie M Weaver; Mark A LaBarge
Journal:  Transl Oncol       Date:  2021-12-30       Impact factor: 4.243

2.  A Decision Aid for Women Considering Neoadjuvant Systemic Therapy for Operable Invasive Breast Cancer: Development and Protocol of a Phase II Evaluation Study (ANZ1301 DOMINO).

Authors:  Nicholas Zdenkowski; Phyllis Butow; Elizabeth Hutchings; Charles Douglas; Joseph R Coll; Frances M Boyle
Journal:  JMIR Res Protoc       Date:  2016-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.